---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-040182"
form_type: "8-K"
ticker: "DRIO"
cik: "0001533998"
company_name: "DarioHealth Corp."
filed_at: "2025-04-28T23:59:59+00:00"
generated_at: "2026-05-23T04:56:59.795868+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# DarioHealth shareholders approve up to 51.7M share issuance and warrant repricing

## Summary
- Vote passed 21.4M for, 0.44M against, 0.08M abstain at special meeting on April 28, 2025.
- Authorizes conversion of 25,605 Series D-3 preferred shares into 33.96M common shares from Dec 2024/Jan 2025 private placements.
- Also authorizes up to 13.58M common shares as dividends on Series D-3 preferred and up to 4.18M shares for lock-up agreements with B/C preferred holders.
- Warrant repricing: 584,882 warrants to Avenue at $0.7208/share; loan conversion up to $2M at $0.8650/share.

## SEC filing metadata
- accession: 0001104659-25-040182
- form_type: 8-K
- ticker: DRIO
- cik: 0001533998
- company_name: DarioHealth Corp.
- filed_at: 2025-04-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533998/000110465925040182/0001104659-25-040182-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533998/000110465925040182/tm2513371d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-040182
- JSON: https://secwatch.observer/filing/0001104659-25-040182.json
- Plain text: https://secwatch.observer/filing/0001104659-25-040182.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.